Galectin-9 induces maturation of human monocyte-derived dendritic cells

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 2974-2981

  Dai, Shu Yan ^a,b   Nakagawa, Ryusuke ^a   Itoh, Aiko ^a   Murakami, Hiromoto ^a   Kashio, Yumiko ^a   Abe, Hiroko ^a   Katoh, Shigeki ^a   Kontani, Keiichi ^a   Kihara, Minoru ^a   Zhang, Shu Lan ^b   Hata, Toshiyuki ^a   Nakamura, Takanori ^a   Yamauchi, Akira ^a   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BETA GALACTOSIDE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ECALECTIN; GALECTIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; LACTOSE; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MONOCYTE; PRIORITY JOURNAL; REPRODUCIBILITY; TH1 CELL; TH2 CELL;

EID: 23844545174     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.2974     Document Type: Article

References (55)

1. Barondes, S. H., V. Castronovo, D. N. Cooper, R. D. Cummings, K. Drickamer, T. Feizi, M. A. Gitt, J. Hirabayashi, C. Hughes, K. Kasai, et al. 1994. Galectins: a family of animal β-galactoside-binding lectins. Cell 76: 597-598.
2. Barondes, S. H., D. N. Cooper, M. A. Gitt, and H. Leffler. 1994. Galectins: structure and function of a large family of animal lectins. J. Biol. Chem. 269: 20807-20810.
3. Asakura, H., Y. Kashio, K. Nakamura, M. Seki, S. Dai, Y. Shirato, M. J. Abedin, N. Yoshida, N. Nishi, T. Imaizumi, et al. 2002. Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9. J. Immunol. 169: 5912-5918.
4. M. Glycobiology 13: 755-763.
5. Zick, Y., M. Eisenstein, R. A. Goren, Y. R. Hadari, Y. Levy, and D. Ronen. 2004. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj. J. 19: 517-526.
6. Perillo, N. L., M. E. Marcus, and L. G. Baum. 1998. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76: 402-412.
7. Perillo, N. L., K. E. Pace, J. J. Seilhamer, and L. G. Baum. 1995. Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739.
8. Kashio, Y., K. Nakamura, M. J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, and M. Hirashima. 2003. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 170: 3631-3636.
9. Liu, F. T. 2000. Galectins: a new family of regulators of inflammation. Clin. Immunol. 97: 79-88.
10. Rabinovich, G. A., L. G. Baum, N. Tinari, R. Paganelli, C. Natoli, F. T. Liu, and S. Iacobelli. 2002. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23: 313-320.
11. Almkvist, J., and A. Karlsson. 2002. Galectins as inflammatory mediators. Glycoconjugate J. 19: 575-581.
12. Hadari, Y. R., K. Paz, R. Dekel, T. Mestrovic, D. Accili, and Y. Zick. 1995. Galectin-8: a new rat lectin, related to galectin-4. J. Biol. Chem. 270: 3447-3453.
13. Wada, J., K. Ota, A. Kumar, E. I. Wallner, and Y. S. Kanwar. 1997. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J. Clin. Invest. 99: 2452-2461.
14. Sano, H., D. K. Hsu, L. Yu, J. R. Apgar, I. Kuwabara, T. Yamanaka, M. Hirashima, and F. T. Liu. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165: 2156-2164.
15. Matsumoto, R., M. Hirashima, H. Kita, and G. J. Gleich. 2002. Biological activities of ecalectin: a novel eosinophil-activating factor. J. Immunol. 168: 1961-1967.
16. Kageshita, T., Y. Kashio, A. Yamauchi, M. Seki, M. J. Abedin, N. Nishi, H. Shoji, T. Nakamura, T. Ono, and M. Hirashima. 2002. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its-clinical significance. Int. J. Cancer 99: 809-816.
17. Abedin, M. J., Y. Kashio, M. Seki, K. Nakamura, and M. Hirashima. 2003. Potential roles of Gal in myeloid differentiation into three different lineages. J. Leukocyte Biol. 73: 650-656.
18. Dietz, A. B., P. A. Bulur, G. J. Knutson, R. Matasic, and S. Vuk-Pavlovic. 2000. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem. Biophys. Res. Commun. 275: 731-738.
19. Matsushita, N., N. Nishi, M. Seki, R. Matsumoto, I. Kuwabara, F. T. Liu, Y. Hata, T. Nakamura, and M. Hirashima. 2000. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J. Biol. Chem. 275: 8355-8360.
20. Nishi, N., A. Itoh, A. Fujiyama, N. Yoshida, S. Araya, M. Hirashima, H. Shoji, and T. Nakamura. 2005. Development of highly stable Gal: truncation of the linker peptide confers protease-resistance on tandem-repeat type Gal. FEBS Lett. 579: 2058-2064.
21. Hirayama, C., and M. Sakata. 2002. Chromatographic removal of endotoxin from protein solutions by polymer particles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781: 419-432.
22. Liu, F. T., D. K. Hsu, R. I. Zuberi, P. N. Hill, A. Shenhav, I. Kuwabara, and S. S. Chen. 1996. Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 14: 6073-6079.
23. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor a. J. Exp. Med. 179: 1109-1118.
24. Arrighi, J. F., M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol. 166: 3837-3845.
25. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494.
26. Lee, J. C., J. T, Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746.
27. Vieira, P. L., P. Kalinski, E. A. Wierenga, M. L. Kapsenberg, and E. C. de Jong. 1998. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 161: 5245-5251.
28. Kalinski, P., C. M. Hilkens, A. Snijders, F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35.
29. Matsumoto, R., H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, and M. Hirashima. 1998. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273: 16976-16984.
30. Nagai, H., M. Ueno, and M. Hirashima. 1994. Selective regulation of chemotactic lymphokine production by monocytes and macrophage cell line cells. Int. Arch. Allergy Immunol. 104(Suppl. 1): 12-14.
31. Chabot, S., Y. Kashio, M. Seki, Y. Shirato, K. Nakamura, N. Nishi, T. Nakamura, R. Matsumoto, and M. Hirashima. 2002. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12: 111-118.
32. Hirashima, M., M. Ueno, N. Saita, S. Takamura, K. Watanabe, S. Tsurufuji, and M. Adachi. 1993. Induction of an eosinophil chemotactic factor production from T lymphocytes by a B cell lymphoma line. Immunol. Lett. 36: 273-281.
33. Hirashima, M., Y. Kashio, N. Nishi, A. Yamauchi, T. A. Imaizumi, T. Kageshita, N. Saita, and T. Nakamura. 2004. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 19: 593-600.
34. Horie, H., Y. Inagaki, Y. Sohma, R. Nozawa, K. Okawa, M. Hasegawa, N. Muramatsu, H. Kawano, M. Horie, H. Koyama, et al. 1999. Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy, J. Neurosci. 19: 9964-9974.
35. Inagaki, Y., Y. Sohma, H. Horie, R. Nozawa, and T. Kadoya. 2000. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur. J. Biochem. 267: 2955-2964.
36. Suk, K., D. Y. Hwang, and M. S. Lee. 1999. Natural autoantibody to galectin-9 in normal human sera. J. Clin. Immunol. 19: 158-165.
37. + T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681-693.
38. + T cells. Eur. J. Immunol. 34: 2708-2719.
39. Banchereau, J., and R, M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
40. Verdijk, R. M., T. Mutis, B. Esendam, J. Kamp, C. J. Melief, A. Brand, and E. Goulmy. 1999. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163: 57-61.
41. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135.
42. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161: 1947-1953.
43. Ishikawa, A., T. Imaizumi, H. Yoshida, N. Nishi, T. Nakamura, M. Hirashima, and K. Satoh. 2004. Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunol. Cell Biol. 82: 410-414.
44. Yoshida, H., T. Imaizumi, M. Kumagai, K. Kimura, C. Satoh, N. Hanada, K. Fujimoto, N. Nishi, K. Tanji, T. Matsumiya, et al. 2001. Interleukin-1β stimulates galectin-9 expression in human astrocytes. NeuroReport 12: 3755-3758.
45. Vray, B., I. Camby, V. Vercruysse, T. Mijatovic, N. V. Bovin, P. Ricciardi-Castagnoli, H. Kaltner, I. Salmon, H. J. Gabius, and R. Kiss. 2004. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 14: 647-657.
46. Steinman, R. M., M. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329: 1-9.
47. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
48. Engleman, E. G. 2003. Dendritic cell-based cancer immunotherapy. Semin. Oncol 30(3 Suppl 8): 23-29.
49. Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10: 475-480.
50. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600.
51. Chaput, N., F. Andre, N. E. Schartz, C. Flament, E. Angevin, B. Escudier, and L. Zitvogel. 2003. Exosomes anti-tumour immunotherapy. Bull. Cancer 90; 695-698.
52. Andre, F., M. Andersen, J. Wolfers, A. Lozier, G. Raposo, V. Serra, C. Ruegg, C. Flament, E. Angevin, S. Amigorena, and L. Zitvogel. 2001. Exosomes in cancer immunotherapy: preclinical data. Adv. Exp. Med. Biol. 495: 349-354.
53. Thery, C., M. Boussac, P. Veron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318.
54. Tsuchiyama, Y., J. Wada, H. Zhang, Y. Morita, K. Hiragushi, K. Hida, K. Shikata, M. Yamamura, Y. S. Kanwar, and H. Makino. 2000. Efficacy of Gal in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int. 58: 1941-1952.
55. Irie, A., A. Yamauchi, K. Kontani, M. Kihara, D. Liu, Y. Shirato, M. Seki, N. Nishi, T. Nakamura, H. Yokomise, and M. Hirashima. 2005. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin. Cancer Res. 11: 2962-2968.